JAC Advance Access originally published online on January 14, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 51, 313-316
© 2003 The British Society for Antimicrobial Chemotherapy
Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species
1 Department of Infectious Diseases, Infection Control & Employee Health, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 402, Houston, TX 77030; 2 Department of Clinical Sciences and Administration, University of Houston College of Pharmacy, Houston, TX; 3 Department of Laboratory Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Received 1 July 2002; returned 13 September 2002; revised 31 October 2002; accepted 19 November 2002
Work in Saccharomyces cerevisiae and Cryptococcus neoformans suggests that caspofungin could interact with the calcineurin pathway. We examined the in vitro interaction of caspofungin with calcineurin inhibitors (FK506, cyclosporin, FK520 and L685,818) and the TOR inhibitor rapamycin in 13 isolates of Aspergillus species. Caspofungin activity was enhanced by calcineurin/TOR inhibitors for all Aspergillus isolates studied. Further investigation of this pathway is warranted.
Keywords: caspofungin, calcineurin inhibitors
* Corresponding author. Tel: +1-713-792-6237; Fax: +1-713-745-6839; E-mail: dkontoyi{at}mdanderson.org
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Dannaoui, P. Schwarz, and O. Lortholary In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes Antimicrob. Agents Chemother., August 1, 2009; 53(8): 3549 - 3551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Cowen and W. J. Steinbach Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance Eukaryot. Cell, May 1, 2008; 7(5): 747 - 764. [Full Text] [PDF]
|
|
|
|
|
|
D. P. Kontoyiannis, R. E. Lewis, B. D. Alexander, O. Lortholary, F. Dromer, K. L. Gupta, G. T. John, R. del Busto, G. B. Klintmalm, J. Somani, et al. Calcineurin Inhibitor Agents Interact Synergistically with Antifungal Agents In Vitro against Cryptococcus neoformans Isolates: Correlation with Outcome in Solid Organ Transplant Recipients with Cryptococcosis Antimicrob. Agents Chemother., February 1, 2008; 52(2): 735 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. P. Wiederhold, D. P. Kontoyiannis, R. A. Prince, and R. E. Lewis Attenuation of the Activity of Caspofungin at High Concentrations against Candida albicans: Possible Role of Cell Wall Integrity and Calcineurin Pathways Antimicrob. Agents Chemother., December 1, 2005; 49(12): 5146 - 5148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Cowen and S. Lindquist Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi Science, September 30, 2005; 309(5744): 2185 - 2189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Singh and D. L. Paterson Aspergillus Infections in Transplant Recipients Clin. Microbiol. Rev., January 1, 2005; 18(1): 44 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Steinbach, N. Singh, J. L. Miller, D. K. Benjamin Jr., W. A. Schell, J. Heitman, and J. R. Perfect In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus Isolates from Transplant and Nontransplant Patients Antimicrob. Agents Chemother., December 1, 2004; 48(12): 4922 - 4925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cuenca-Estrella Combinations of antifungal agents in therapy-what value are they? J. Antimicrob. Chemother., November 1, 2004; 54(5): 854 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Kaatz and S. M. Seo Effect of substrate exposure and other growth condition manipulations on norA expression J. Antimicrob. Chemother., August 1, 2004; 54(2): 364 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Steinbach, W. A. Schell, J. R. Blankenship, C. Onyewu, J. Heitman, and J. R. Perfect In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1664 - 1669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Johnson, C. MacDougall, L. Ostrosky-Zeichner, J. R. Perfect, and J. H. Rex Combination Antifungal Therapy Antimicrob. Agents Chemother., March 1, 2004; 48(3): 693 - 715. [Full Text] [PDF]
|
|